Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 10 studies | 27% ± 8% | |
classical monocyte | 5 studies | 32% ± 16% | |
epithelial cell | 5 studies | 21% ± 5% | |
basal cell | 5 studies | 32% ± 24% | |
secretory cell | 5 studies | 35% ± 22% | |
monocyte | 4 studies | 21% ± 4% | |
myeloid cell | 4 studies | 28% ± 10% | |
ciliated cell | 4 studies | 25% ± 9% | |
neutrophil | 3 studies | 34% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 94% | 1109.58 | 541 / 578 | 69% | 79.35 | 796 / 1155 |
intestine | 59% | 357.38 | 566 / 966 | 93% | 129.72 | 489 / 527 |
stomach | 41% | 120.52 | 146 / 359 | 87% | 131.47 | 249 / 286 |
liver | 54% | 409.21 | 121 / 226 | 67% | 75.70 | 273 / 406 |
kidney | 84% | 267.40 | 75 / 89 | 35% | 27.87 | 319 / 901 |
esophagus | 33% | 138.71 | 484 / 1445 | 79% | 102.40 | 144 / 183 |
pancreas | 40% | 35.65 | 130 / 328 | 70% | 45.45 | 124 / 178 |
bladder | 48% | 47.14 | 10 / 21 | 46% | 48.90 | 230 / 504 |
skin | 67% | 219.61 | 1203 / 1809 | 10% | 6.04 | 45 / 472 |
tonsil | 0% | 0 | 0 / 0 | 76% | 155.88 | 34 / 45 |
uterus | 9% | 7.13 | 15 / 170 | 47% | 47.73 | 216 / 459 |
prostate | 42% | 83.37 | 104 / 245 | 6% | 1.67 | 30 / 502 |
ovary | 7% | 12.03 | 13 / 180 | 33% | 21.80 | 144 / 430 |
peripheral blood | 35% | 54.07 | 327 / 929 | 0% | 0 | 0 / 0 |
adipose | 30% | 140.89 | 360 / 1204 | 0% | 0 | 0 / 0 |
breast | 19% | 22.09 | 89 / 459 | 5% | 1.95 | 59 / 1118 |
thymus | 13% | 7.26 | 84 / 653 | 10% | 7.11 | 59 / 605 |
blood vessel | 17% | 21.93 | 222 / 1335 | 0% | 0 | 0 / 0 |
brain | 10% | 13.57 | 273 / 2642 | 3% | 1.39 | 24 / 705 |
adrenal gland | 8% | 7.09 | 21 / 258 | 2% | 0.90 | 4 / 230 |
heart | 10% | 29.34 | 84 / 861 | 0% | 0 | 0 / 0 |
spleen | 9% | 4.88 | 22 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 2.32 | 2 / 29 |
muscle | 2% | 0.82 | 13 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006954 | Biological process | inflammatory response |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0007165 | Biological process | signal transduction |
GO_0006935 | Biological process | chemotaxis |
GO_0007267 | Biological process | cell-cell signaling |
GO_0006955 | Biological process | immune response |
GO_0072679 | Biological process | thymocyte migration |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0042742 | Biological process | defense response to bacterium |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_2000406 | Biological process | positive regulation of T cell migration |
GO_0072678 | Biological process | T cell migration |
GO_0060326 | Biological process | cell chemotaxis |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0008009 | Molecular function | chemokine activity |
GO_0048020 | Molecular function | CCR chemokine receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0031731 | Molecular function | CCR6 chemokine receptor binding |
Gene name | CCL20 |
Protein name | C-C motif chemokine ligand 20 C-C motif chemokine 20 (Beta-chemokine exodus-1) (CC chemokine LARC) (Liver and activation-regulated chemokine) (Macrophage inflammatory protein 3 alpha) (MIP-3-alpha) (Small-inducible cytokine A20) [Cleaved into: CCL20(1-67); CCL20(1-64); CCL20(2-70)] |
Synonyms | SCYA20 MIP3A LARC |
Description | FUNCTION: Acts as a ligand for C-C chemokine receptor CCR6. Signals through binding and activation of CCR6 and induces a strong chemotactic response and mobilization of intracellular calcium ions . The ligand-receptor pair CCL20-CCR6 is responsible for the chemotaxis of dendritic cells (DC), effector/memory T-cells and B-cells and plays an important role at skin and mucosal surfaces under homeostatic and inflammatory conditions, as well as in pathology, including cancer and various autoimmune diseases . CCL20 acts as a chemotactic factor that attracts lymphocytes and, slightly, neutrophils, but not monocytes . Involved in the recruitment of both the pro-inflammatory IL17 producing helper T-cells (Th17) and the regulatory T-cells (Treg) to sites of inflammation. Required for optimal migration of thymic natural regulatory T cells (nTregs) and DN1 early thymocyte progenitor cells (By similarity). C-terminal processed forms have been shown to be equally chemotactically active for leukocytes . Positively regulates sperm motility and chemotaxis via its binding to CCR6 which triggers Ca2+ mobilization in the sperm which is important for its motility . Inhibits proliferation of myeloid progenitors in colony formation assays . May be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells (By similarity). Possesses antibacterial activity towards E.coli ATCC 25922 and S.aureus ATCC 29213 . . |
Accessions | ENST00000409189.7 [P78556-2] ENST00000646475.1 A0A2R8Y806 ENST00000358813.5 [P78556-1] P78556 |